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We recently found that polyclonal antibodies to laminin, a basement membrane-related glycoprotein, inhibited mu- 
rine lung morphogenesis when added to organ cultures of mouse embryonic lung. Using a series of monoclonal anti- 
laminin antibodies with previously characterized subunit specificity (termed AL-l, AL-2, AL-3, AL-4, and AL-5), the 
deposition and functional involvement of different laminin domains in the developing lung were investigated. By im- 
munohistochemistry the antibodies’ reactivity was largely localized to the basement membrane, but was also present 
diffusely in the extracellular matrix throughout the mesenchyme. Organ cultures of lung explants from Day 12 embryos 
were cultured for 3 days in the presence of 50-100 Kg/ml of each antibody or in the presence of the same concentration of 
immunoglobulins G and M, laminin-neutralized antibody, or medium alone. Cultures were monitored by phase-contrast 
microscopy, light microscopy, and immunofluorescence. Although all antibodies penetrated the tissues in culture, only 
two of them inhibited branching activity. These two antibodies were AL-l, which binds on or near the cross region of 
laminin, and AL-5, which binds to the lateral short arms at the globular end regions of the B chain of laminin. Inhibition 
of branching with these two antibodies was dose-dependent and statistically significant for the two concentrations used. 
AL-2, AL-3, AL-4, laminin-neutralized antibodies and control immunoglobulins did not alter lung morphogenesis. The 
two domains of laminin that promote lung branching morphogenesis have been reported by others to promote the 
attachment of a variety of cells and/or bind heparin. These domains of laminin may promote branching morphogenesis 
by facilitating cell attachment and, consequently, cell proliferation. e 1991 Academic PWSS, ITIC. 
INTRODUCTION 
Laminin is a multidomain glycoprotein localized 
mainly in basement membranes. As isolated from the 
Englebreth-Holm-Swarm (EHS) tumor and many 
other tissues, laminin is composed of three polypeptide 
chains, referred to as Bl (M, 222,000), B2 (M, 210,000), 
and A (M, 4,000,OOO). The chains are held together by 
disulfide bonds to form a cross-shaped molecule (Timpl 
et al., 1979). The complete amino acid sequences of all 
three chains of EHS laminin have been recently pub- 
lished (Sasaki et al., 198’7; Sasaki and Yamada, 1987; Sa- 
saki et a,Z., 1988). Laminin has diverse effects on a variety 
of cells, including stimulation of adhesion, migration, 
growth, and differentiation (Martin and Timpl, 1987; 
Kleinman et al., 1987a). Studies with proteolytic frag- 
ments, domain-specific antibodies, and synthetic pep- 
tides have identified different regions of laminin with 
biological activity. Two of the major cell binding regions 
are localized at the cross intersection (Terranova et ah, 
1983; Skubitz et al., 1987; Graf et al., 1987; Charonis et al., 
1988; Kleinman et al., 1989) and at the terminal end of 
the long arm (Aumailley ef aZ., 1987; Goodman et al, 
1987; Tashiro et a,Z., 1989). 
Laminin is already present in early preimplantation 
embryos (Cooper and MaeQueen, 1983) and thereafter is 
largely restricted to basement membranes of a variety 
of tissues during all stages of development (Wu et al., 
1983). Recent studies of kidney organogenesis have 
shown that the different laminin chains are not coordi- 
nately expressed during embryogenesis, suggesting that 
molecular isoforms might also exist (Ekblom et al, 1990; 
Kleinman et al., 1987b; Laurie et al, 1989). Relying, in 
part, on the existence of these spatial and temporal dis- 
tributions of the molecule and their coincidence with 
key developmental events, laminin has been postulated 
to be instrumental for organ development (Ekblom et 
al, 1980, 1986, 1990; Martin and Timpl, 1987). 
In a recent study, we established that laminin plays 
an important role in the morphogenesis of embryonic 
mouse lung. Using polyclonal antibodies to laminin, we 
demonstrated that the antibodies were able to penetrate 
lung tissue in organ culture, localize at the basement 
membrane, and interfere with branch formation. Anti- 
bodies to two other components of the extracellular ma- 
trix, thrombospondin and entactin, failed to alter the 
normal pattern of development (Schuger et al., 1990; un- 
published). These findings are extended in the current 
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FIG. 1. Diagrammatic models of the monoclonal antibody binding 
sites on laminin Anti-laminin monoclonal antibodies AL-l, Al-Z, Al-3, 
AL-4, and AL-5 were incubated with laminin and analyzed by electron 
microscopy after rotary shadowing. (Skubitz et al, 1987, 1988). 
investigation using a series of monoclonal antibodies to 
distinct domains of laminin. We demonstrate that the 
inhibition observed is the result of interference with 
functions that can be localized to specific regions of the 
laminin molecule. 
MATERIALS AND METHODS 
Isolation and culture of embryonic lungs. CD-l strain 
(Charles River) mice were mated and the day a vaginal 
plug was found designated as Day 0. Pregnant females 
were sacrificed by cervical dislocation on Day 12 of ges- 
tation. Uteri were removed to sterile phosphate-buff- 
ered saline (PBS), and the lungs were dissected from the 
embryos with watchmakers forceps using a dissecting 
microscope. The lower right lobe was further dissected 
and cultured at the air-medium interface on the upper 
surface of polycarbonate filter membrane assemblies, 
0.4-pm pore size, (Millipore, Bedford, MA). The culture 
medium used was minimal essential medium, (GIBCO, 
Grand Island, NY) containing 10% fetal calf serum (Hy- 
clone Lab, Logan, UT), nonessential amino acids 
(GIBCO), 0.29 mg/ml L-glutamine (Irvine Scientific, 
Santa Ana, CA), 100 U/ml penicillin, 100 pg/ml strepto- 
mycin, and 0.25 pg/ml amphotericin B (Irvine Scien- 
tific). Cultures were incubated at 37°C in 5% CO, and 
fed daily by a complete change of medium. 
Lung explants maintained in organ culture continue 
to develop in vitro. The transparency of the tissue, plus 
the transparency of the polycarbonate filter in which 
the organ buds are grown, allows continuous monitoring 
of epithelial branching morphogenesis. By Day 12 of 
gestation (at the time that the lungs are dissected), the 
right lower lobe presents four to six terminal buds. 
After 3 days in culture there is a lo-fold or greater in- 
crease in the number of terminal buds. 
Anti-laminin mono&ma1 antibodies. Five monoclonal 
antibodies (AL-l to AL-5) were generated against lam- 
inin by immunization of male LOU/MNCr rats. The 
preparation, purification, and characterization of these 
antibodies have been previously described (Skubitz et 
al., 1987, 1988). All of the antibodies were of the IgG 
class except AL-5, which was an IgM; each antibody 
reacted with laminin by solid phase radioimmunoassay 
and radioimmunoprecipitation (Skubitz et al., 1987, 
1988). The regions on laminin to which each antibody 
bound (Fig. 1) were determined by Western immunoblot- 
ting in combination with electron microscopy (Skubitz 
et al., 1987, 1988). Normal rat IgG and normal rat IgM 
were purchased from Cappel (Malvern, PA). 
Conjugation of antibody with jkn-ochrome. For some 
studies, selected monoclonal antibodies were conjugated 
with fluorescein isothiocyanate (FITC) according to the 
technique described by Goding, (1976). Briefly, 2 mg/ml 
of antibody in 0.1 M sodium carbonate buffer, pH 9.0, 
was incubated with 50 yl of FITC (Molecular Probes, 
Eugene, OR) dissolved in DMSO at 1 mg/ml. This mix- 
ture was incubated at 4°C in the dark for 8 hr. Then NH, 
Cl was added at a final concentration of 50 mM and the 
mixture reaction was incubated at 4°C for another 2 hr. 
The reaction was stopped with xylene cyan01 and glyc- 
erol at a final concentration of 0.1 and 5%) respectively. 
The free FITC was separated from the FITC-antibody 
conjugates on a 25-ml G-50-80 column (Sigma) equili- 
brated in 1 X PBS. Optical densities per each antibody 
were taken (FITC at 495 nm and protein at 280 nm) and 
the fluorochrome:protein ratio was calculated. All the 
ratios fell into the optimal range (0.3 to 1.0). 
Culture of lung explants in the presence of monoclonal 
antibodies to laminin and control immunoglobulins. 
Right lower lobes dissected from embryonic lungs at 
Day 12 of gestation were cultured for 3 days in the pres- 
ence of various purified monoclonal antibodies or con- 
trol normal rat immunoglobulins from the classes G 
(IgG) and M (IgM). The antibodies, as well as the control 
IgG and IgM, were added to the wells in 100 cl1 of PBS at 
a final concentration of 50 or 100 pg/ml. The culture 
medium was replaced daily and antibody or control im- 
munoglobulin replenished. For additional control ex- 
periments, the explants were left untreated. The experi- 
ments were repeated six times, providing a total of 12 
explants for each antibody or control at 100 pg/ml and 8 
explants for each antibody and control at 50 pg/ml. In 
two additional experiments, anti-laminin antibodies at 
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a concentration of 100 yg/ml were preadsorbed with 100 
pg of laminin for 1 h prior to being introduced into the 
medium. 
As previously reported (Schuger et ab, 1990), branch- 
ing morphogenesis was monitored and photographed 
using a phase-contrast microscope and the number of 
terminal branches was recorded daily. At the end of 
each experiment, the percentage of branching inhibition 
per explant was calculated as 
No. terminal buds in treated explants (a) 
- No. terminal buds at time zero (b) x 1oo 
No. terminal buds in control explants (c) 
- No. terminal buds at time zero 
(a) Treated explants included those cultured in the pres- 
ence of antibody or control immunoglobulin. (b) No. of 
terminal buds at time zero ranged from 4 to 6. (c) Con- 
trol explants were those left untreated. 
Immunohistoch,emistry. Lungs removed from Day 12 
embryos were immediately frozen in OCT embedding 
compound (Miles, Naperville, IL). Blocks were stored at 
-70°C prior to sectioning. Ten-micrometer sections 
were cut and collected on polylysine-coated slides. Sec- 
tions were air dried and exposed in a moist chamber to 
400 U/ml bovine testes hyaluronidase (Cappel) for 20 
min. Sections were then exposed to 5% normal goat 
serum followed by the primary antibody for 2 hr at room 
temperature. Monoclonal antibodies AL-l, AL-2, A-3, 
and AL-4 (all IgG’s) and normal rat IgG were used at a 
dilution of 1:lO; monoclonal antibody AL-5 (an IgM) and 
normal rat IgM were used at a dilution of 1:50. The sec- 
tions were then washed in PBS and exposed to a 150 
dilution of the secondary antibody (FITC-conjugated 
goat anti-rat IgG or IgM; Cappel) for 30 min at room 
temperature. Sections were washed extensively in PBS 
and coverslipped with glycerol containing 0.1% phenyl- 
enediamine (Sigma, St. Louis, MO). As an additional 
control, sections were also treated with just PBS con- 
taining no primary immunoglobulin. In further studies, 
tissue sections were consecutively exposed to two differ- 
ent monoclonal antibodies. For these experiments the 
second antibody was FITC-conjugated. The purpose of 
these studies was to determine possible sharing of tissue 
binding sites by different antibodies. If this is indeed 
the case, then it could be expected that incubation of a 
tissue section with the proper antibody will block fur- 
ther binding of a second, FITC-conjugated antibody. In 
contrast, if the two antibodies do not share common tis- 
sue binding sites then the positive stain observed with 
an FITC-conjugated antibody should not be abolished 
by previous exposure of the section to the first antibody. 
To determine penetration and immunolocalization of 
the various monoclonal antibodies in the explants, tis- 
sues were incubated with the appropriate monoclonal 
antibody or with control immunoglobulin for 24 hr. Sam- 
ples were then frozen in situ by filling the membrane 
assembly with OCT at -20°C. The samples were then 
processed for immunohistochemistry as above except 
that the primary antibody was omitted during the im- 
munostaining procedure. 
Light microscopy. Lung explants unexposed or ex- 
posed to the different antibodies were examined under 
light microscopy. For morphological detail and assess- 
ment of tissue preservation after culture, lung explants 
were fixed in 10% phosphate-buffered formalin, rinsed 
with PBS, and dehydrated through graded alcohols to 
100%. The samples were embedded in glycolmethacry- 
late (Polysciences, Warrington, PA). Five-micrometer 
sections were cut, mounted on slides, and stained with 
hematoxylin-eosin. 
Mitotic activity was determined on frozen sections 
from lung explants exposed for 48 hr to the various 
monoclonal antibodies (100 yg/ml). Control explants 
were left unexposed or exposed to IgG. Total number of 
mitotic figures in the mesenchymal and epithelial com- 
partments was determined by screening 16 fields (mag- 
nification 80) per explant. 
RESULTS 
Immunolocalixation studies. All five of the monoclonal 
antibodies were immunoreactive with the embryonic 
lung tissue. AL-l, which in Western immunoblots recog- 
nizes the A chain and binds to the cross region of lami- 
nin (Fig. l), stained the epithelial basement membrane 
and, to a minor degree, the extracellular matrix com- 
partment (Fig. 2A). AL-2, which recognizes A and B 
chains and binds to the long arm of the molecule near 
the cross region, presented a very similar pattern of re- 
activity (Fig. 2B). AL-3 and AL-4, which recognize B and 
A chains, respectively, and bind, the former to the inner 
rod segment of the B chain(s) and the latter to the car- 
boxy1 end of the A chain, stained only the epithelial base- 
ment membrane (Figs. 2C and 2D). Al-5, which binds to 
the globular segments of the lateral short arms (B 
chains), reacted weakly with the epithelial basement 
membrane and presented a pattern of diffuse staining 
throughout the extracellular matrix (Fig. 2E). None of 
the antibodies recognized vascular basement mem- 
branes. The data are summarized in Table 1. 
Eflects of monoclonal anti-lam&in antibodies on lung 
branching morphogenesis. We next examined the effects 
of the monoclonal antibodies on lung morphogenesis. 
Branch formation was measured as described under Ma- 
terials and Methods. Consistent with our previous re- 
port (Schuger et ah, 1990), organ cultures of 12-day em- 
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FIG. 2. Immunohistochemical localization of laminin in the 12.day embryonic mouse lung. The immunostain obtained with each antibody is 
shown in the corresponding H&E counterstain for each is shown in the right-hand panels. An epithelial bud at Day 12 of gestation surrounded 
by mesenchyme is shown in each photograph. The airway lumen is approximately in the center of the photograph. Monoclonal antibodies AL-1 
and AL-Z (A.B) stain predominantly the epithelial basement membrane. The mesenchymal extracellular matrix is stained diffusely. Antibodies 
AL-3 and AL-4 (C,D) react exclusively with the epitheliai basement membrane. Antibody AL-5 (E) appears to diffusely stain the extracellular 
matrix and the epithelial basement membrane. Normal rat immunoglobulin IgG does not stain any of the lung (F). Scale bar, 100 Mm. 
bryonic mouse lung underwent active branch formation were observed in explants cultured in the presence of 
over the subsequent 3-day period. The mean number of 100 pg/ml of normal rat IgG (Fig. 3A) or normal rat IgM 
terminal buds by the third day in control cultures was 53 or in the presence of an equal concentration of AL-2, 
(SD = ‘7; range 49-80). Similar numbers of branches AL-3 (Fig. 3C), or AL-4. In contrast, AL-l and AL-5 
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significantly decreased the number of terminal buds 
(Figs. 3E and 3G, respectively). Qualitative differences 
in the pattern of branching of the affected explants 
were observed with both antibodies. Their branching 
configuration was irregular and accompanied by seg- 
mental dilatation (Figs. 3E and 3G). Inhibition was con- 
centration-dependent over the range 50-100 pg/ml. The 
decrease in the number of branches was evident after 1 
day in culture. By the second day in culture, at which 
time antibody effect was maximal, the percentage of 
branching inhibition was greater than 30% for antibody 
concentration of 100 pg/ml (Fig. 4) and 18% for anti- 
body concentration of 50 pg/ml (not shown). Significant 
inhibition was still observed after 3 days but there was 
more variability among the different explants in the 
same treatment groups. The inhibition observed with 
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TABLE 1 
IMMLINOHISTOCHEMICAL STUDIES ON MOUSE EMBRYONIC LUNG 
(DAY 12 OF GESTATION) 
MOIWClOnal” 
antibody Laminin domainb 
Distribution” 
Diffuse BM-Restricted 
AL-l Cross intersection ++ ++t+ 
AL-2 Long arm below bifurcation ++ +++t 
AL-3 Lateral arms, inner segment 0 +++t 
AL-4 Long arm, carboxy end 0 ++t+ 
AL-5 Lateral arms, outer segment t+++ ++ 
Normal IgG 0 0 
Normal IgM 0 0 
*The generation and characterization of these antibodies have been 
previously described (Shubitz et al., 1987, 1988). 
*Localization of monoclonal antibody binding to domains of lami- 
nin was determined by electron microscopy as previously described 
(Shubitz et al., 1987, 1988). See Fig. 1. 
“Distribution was classified as either diffuse or restricted to the 
basement membrane (BM, No reactivity was scored as 0, while posi- 
tive levels of reactivity were scored from + (low) to ++++ (high). 
AL-l and AL-5 was statistically significant at both con- 
centrations used (50 and 100 pg/ml) after 1 and 2 days. 
After 3 days, statistical significance was observed only 
at the highest concentration. The effects of both AL-l 
and AL-5 were abrogated by preadsorption with 100 pg 
of laminin for 60 min prior to use. 
Immunojuorescence localization of the antibodies in 
the lung explants after antibody treatment. Immunohis- 
tochemistry was used to assess the efficiency of the anti- 
bodies added to the organ cultures to penetrate the ex- 
plants. For these experiments, lung explants were cul- 
tured for 2 days in the presence of monoclonal 
antibodies and control IgG or IgM as described under 
Materials and Methods. At the end of the treatment pe- 
riod, frozen sections obtained from the treated and con- 
trol explants were exposed directly to an FITC-conju- 
gated goat Fab fragment of anti-rat IgG or anti-rat 
IgM. These experiments showed that all of the monoclo- 
nal antibodies effectively penetrated the lung tissue 
during the course of the experiments and reacted with 
the appropriate tissue epitopes. The patterns of reactiv- 
ity seen in the organ cultures were very similar to those 
observed originally when the antibodies were used for 
conventional immunohistochemistry on fresh, uncul- 
tured lungs. Antibodies AL-l, AL-2, AL-3, and AL-4 
reacted primarily with the basement membrane while 
AL-5 was reactive with groups of cells in close proximity 
to the airway lumen (Figs. 3D, 3F, 3H). However, AL-l 
and AL-2 immunoreactivity was not diffusely present in 
the extracellular matrix as was observed in the immu- 
nolocalization studies done on fresh, uncultured lungs. 
At the end of the incubation period, lung explants 
were examined histologically for tissue viability. A 
complete preservation of tissue architecture was ob- 
served in all cases. Mitotic figures and occasional single 
necrotic cells were seen in both treated and control ex- 
plants (Fig. 5). Thus, there were no cytological abnor- 
malities associated with inhibition of branch formation. 
Eflects of mono&ma1 anti-lam&in antibodies on mi- 
totic activity. Lung explants were cultured for 2 days in 
the presence of monoclonal antibodies AL-l or AL-5 or 
in the presence of IgG as described under Materials and 
Methods. At the end of this period the number of mitotic 
figures was determined on frozen sections obtained 
from three explants exposed to AL-l, three explants ex- 
posed to AL-5, two exposed to IgG, and one unexposed. 
Both AL-l and AL-5 significantly decreased the number 
of mitotic figures in the epithelium compared to unex- 
posed lungs or lungs exposed to control IgG. (In one ex- 
periment the epithelium of lung explants exposed to 
AL-l and AL-5 presented 45 and 40 mitotic figures/ex- 
plant, respectively, compared to 73 in IgG exposed ex- 
plant.) However, we did not see a decrease in mitotic 
figures in the mesenchymal compartment of the AL-l- 
and AL-5-treated explants. In fact, there was actually 
an increase in the number of mesenchymal mitotic fig- 
ures in these explants. In the experiment presented 
above, the mesenchyme of lungs exposed to AL-1 and 
AL-5 showed 43 and 40 mitotic figures/explant, respec- 
tively, compared to 22 in IgG exposed explant. The ex- 
periments were repeated in three instances with similar 
results. The significance of this is not known at present. 
Immunohistochemical studies with a combination of 
unlabeled and FITC-labeled mono&ma1 antibodies. Im- 
munohistochemistry was used to determine whether the 
positive stain obtained with FITC-conjugated antibod- 
ies AL-l and AL-5 could be blocked by preincubation of 
the tissue sections with unconjugated AL-l or AL-5. In 
these studies preincubation of the tissue sections with 
unconjugated AL-l did not inhibit binding of AL-5- 
FITC. AL-5-FITC presented a positive pattern identical 
to that obtained by conventional immunohistoche- 
mistry. As expected, unconjugated AL-5 inhibited bind- 
ing of FITC-conjugated AL-5. Unfortunately, AL-l- 
FITC did not bind to the tissue sections, even under con- 
trol conditions. 
DISCUSSION 
In previous studies we found that when embryonic 
lung explants were cultured in the presence of polyclo- 
nal antibodies to laminin, branching morphogenesis 
was inhibited and gross abnormalities occurred 
(Schuger et al., 1990). Like other extracellular matrix 
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glycoproteins, laminin is a multidomain macromolecule 
and its diverse biological activities are mediated by dif- 
ferent segments of the protein in a way that seems to be 
cell-type or function specific. In order to determine 
whether the involvement of laminin in branching mor- 
phogenesis could be further localized to a particular do- 
main, embryonic lung explants were cultured in the 
presence of monoclonal antibodies to various domains of 
the laminin molecule and their effect on morphogenesis 
was determined. The laminin domains to which each of 
the antibodies used in the present study localize have 
been established in previous reports by electron micros- 
copy, and the laminin chains to which each antibody 
reacts have been determined by immunoblotting and ra- 
dioimmunoassay (Skubitz et al., 1987, 1988). All of the 
domains recognized by the antibodies have been re- 
ported to promote cell attachment (Terranova et al, 
1983; Graf et al., 1987; Aumailley et ah, 1987; Skubitz et 
al., 1987; Charonis et al., 1988; Kouzi-Koliakos et ah, 1989; 
Kleinman et aZ., 1989; Tashiro et al., 1989). In addition, 
some of these domains have heparin binding activity 
(Skubitz et ab, 1988). 
In the present study monoclonal antibodies were used 
first to determine laminin distribution in the 12th day 
embryonic lung and second to evaluate the functional 
involvement of different laminin domains in lung mor- 
phogenesis. The immunohistochemical studies localized 
laminin predominantly to the basement membrane. 
However, some immunoreactivity was also diffusely 
present in the extracellular matrix. Since it is unlikely 
that laminin produced by epithelial cells extends beyond 
the basement membrane into the mesenchymal extra- 
cellular matrix, our findings suggest that laminin is ex- 
pressed by both the epithelial and the mesenchymal 
cells. These findings coincide with previous studies con- 
ducted on other developmental systems, in which a dual 
tissue origin of laminin was demonstrated (Simon-Ass- 
mann et al., 1988). The fact that not all of the monoclonal 
antibodies reacted with the laminin diffusely present in 
the extracellular matrix might indicate the existence of 
molecular isoforms differing structurally from each 
other. Alternatively, the lack of diffuse extracellular 
matrix staining with certain monoclonal antibodies 
may be due to masking of the appropriate epitopes. 
Blocking experiments to determine the functional in- 
volvement of laminin in lung morphogenesis showed 
that two of the five antibodies interfered with organo- 
genesis: antibody AL-l, which binds at the cross region 
of laminin, and antibody AL-5, which recognizes the 
globular segments of the B chain(s) (Skubitz et aZ,, 1987, 
1988). Both antibodies inhibited branching morphogen- 
esis in a concentration-dependent manner and this ef- 
fect was abrogated by preincubation with laminin. Lung 
explants exposed to AL-5 presented severe alterations 
in the pattern of branching. These kind of alterations 
were uncommon in those explants exposed to AL-l, sug- 
gesting that the two antibodies may be blocking differ- 
ent laminin functions. There was no evidence of cytotox- 
icity with either AL-l or AL-5. However, explants ex- 
posed to both antibodies were smaller than controls and 
presented a decrease in the total number of mitotic fig- 
ures. Interestingly, the inhibition in mitotic activity ap- 
peared to be specific for epithelial cells. There was no 
inhibition in the mesenchymal compartment. In fact, 
mitotic figures were prominent among mesenchymal 
cells. These observations suggest a complex effect of the 
antibodies on lung organogenesis rather than a general 
antiproliferative activity. 
Failure of the other three monoclonal antibodies to 
interfere with branching morphogenesis was not due to 
inability to penetrate the lung tissue in organ culture, 
since immunolocalization studies demonstrated that 
during culture all five antibodies penetrated the lung 
and bound to the basement membrane or, in the case of 
AL-5, reacted with cells close to the basement mem- 
brane. 
It should be noted that the binding sites of antibodies 
AL-2 and AL-3, which did not affect branching, present 
partial overlap with the binding site of AL-l, which in- 
hibited branching activity. The difference in effect may 
indicate that among these antibodies, the effective one 
is that which is able to bind at high concentration to a 
relatively small key segment in the molecule. Even 
more, blocking of critical amino acid sequences might be 
required to obtain an effect. Studies using synthetic 
peptides representing sequences from critical laminin 
sites will help to answer this question. 
The current studies indicate that specific determi- 
nants of laminin appear to be required in order for the 
laminin molecule to be functionally active during lung 
morphogenesis. In previous studies using polyclonal an- 
tibodies to laminin, we could not rule out the possibility 
that inhibition of morphogenesis was caused merely by 
steric hindrance of the polyclonal antibody bound to the 
basement membrane. However, in this study using 
monoclonal antibodies we can ensure that only specific 
domains of laminin are blocked by each of the antibod- 
ies. Based on our results, we can suggest the following 
scenario to account for this inhibition of branching 
morphogenesis with monoclonal antibodies. Laminin 
synthesized by epithelial cells and probably also by mes- 
enchymal cells becomes organized into a basement 
membrane. Epithelial cell receptors for laminin recog- 
nize segments at the cross-shaped part of the molecule 
or in the globular region of the short arms. The cells 
bind to these parts of laminin and carry out the func- 
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tions needed for normal morphogenesis. Alternatively, 
inhibition of normal morphogenesis might not be the 
result of blocking laminin functions in the basement 
membrane but rather of the blocking of laminin dif- 
fusely present in the extracellular matrix. In such case, 
it may be the mesenchymal cell interaction with laminin 
that is affected. While this is speculative, the finding 
that the two antibodies that inhibited morphogenesis 
showed diffuse extracellular matrix reactivity supports 
such a possibility. 
With regard to AL-5 specifically, this antibody pre- 
sented a staining pattern that was distinct from the 
other antibodies. This antibody stained the mesenchy- 
ma1 compartment but failed to stain the basement 
membrane. On this basis, it could be suggested that AL- 
5 reactivity was due to interaction with molecules other 
than laminin however this is unlikely. Rotary shadow 
electron microscopy studies clearly demonstrated that 
AL-5 binds to a specific laminin region. This region, 
which is located at the terminal part of the lateral arms, 
has both cell binding and heparin binding activity (Sku- 
bitz, 1987, 1988; Kouzi-Koliakos, 1989). AL-5 inhibits 
both heparin binding to laminin and cell adhesion to 
laminin (Skubitz, 1987,1988; Kouzi-Koliakos, 1989). It is 
evident from this that AL-5 recognizes epitopes on the 
laminin molecule and interferes with functions that are 
dependent on the same region of the molecule in which 
the epitopes reside. It should be pointed out that mesen- 
chymal cells isolated from E-day mouse embryo lungs 
synthesize laminin in primary culture (manuscript in 
preparation). Therefore, it would not be unreasonable to 
see staining of the mesenchymal compartment. Further 
while the lack of basement membrane staining with 
AL-5 is curious, it may be possible that the epitope for 
this antibody is either masked or not present in suffi- 
cient quantity to elicit a response with this antibody. (If 
the antibody were recognizing something in addition to 
laminin, this would not explain its lack of staining of the 
basement membrane.) Interestingly, it appears that the 
lack of basement membrane staining with AL-5 is devel- 
opmentally regulated. When lungs form 14-day embryos 
are stained with this antibody, there is basement mem- 
brane staining as well as staining of the mesenchymal 
compartment (manuscript in preparation). Most impor- 
tantly, incubation of soluble laminin with AL-5 com- 
pletely abrogated its ability to interfere with normal 
mouse lung development. This is identical to what we 
saw when soluble laminin was incubated with AL-l, the 
other antibody which interferes with lung development. 
If a moiety other than laminin were responsible for reac- 
tivity with this antibody, soluble laminin would not be 
expected to compete. Taken together, these data 
strongly suggest that laminin is the antigen for AL-5 
and that the unusual staining pattern seen in the 12-day 
mouse embryo lungs cannot be explained on the basis of 
failure to react with laminin. 
How specific domains of laminin act to promote 
branching morphogenesis and how antibodies interfere 
with their biological activity are important questions 
that remain to be elucidated. Many possibilities should 
be considered. In recent years it has become clear that 
cell attachment, proliferation, migration, and polariza- 
tion (all essential to normal morphogenesis) result from 
cell interactions with specific laminin domains. It is, 
therefore, possible that the two laminin domains de- 
fined in this study mediate one or more of the above 
functions. It is even possible that each of these domains 
serves a different function during lung development and 
that blocking of morphogenesis is an end result of inter- 
fering with one of several diverse biological processes. 
The ability of several laminin domains to promote cell 
attachment in a cell-type-dependent manner has been 
extensively documented. Both the cross region of la- 
minin and the globular domains of the B chain(s) have 
been reported to promote the attachment of a variety of 
cells. (Terranova et oh, 1983; Graf ef uh, 1987; Charonis et 
al., 1988, Kouzi-Koliakos et al., 1989; Kleinman et oh, 
1989; Tashiro et al., 1989). Proliferation of epithelial and 
mesenchymal cells, the two main cell populations of the 
embryonic lung, is an anchorage-dependent phenome- 
non. If the two laminin domains defined in this study 
promote the attachment of embryonic lung cells, then 
cell proliferation and consequentially branching mor- 
phogenesis could be facilitated by these domains. It fol- 
lows that interfering with the functions of these critical 
domains could lead to an inhibition of branching mor- 
phogenesis. Conversely, if the binding of laminin to 
other basement membrane constituents such as proteo- 
glycans or even laminin itself (Timpl, 1989) is perturbed, 
then a proper assembly of the basement membrane may 
not take place. This could also result in impaired mor- 
phogenesis. It should be noted in this regard that the 
FIG. 3. Left-hand column: Effects of monoclonal antibodies on branching morphogenesis. Lung organ cultures were established on Day 0 and 
incubated for 2 days in the presence of 100 pg/ml of normal rat IgG (A), antibody AL-3 (C), antibody AL-1 (E), or antibody AL-5 (G). Normal 
branching morphogenesis occurred in the explants exposed to IgG (A) or AL-3 (C). Inhibition in branching activity is evident in the cultures 
exposed to AL-l (E) and AL-5 (G). Right-hand column: Assessment of antibody penetration into the explant during organ culture treatment. No 
immunoglobulin is bound to the tissue when the explants are cultured in the presence of normal rat IgG (B). When explants are cultured in the 
presence of AL-3 (D) or AL-l (F), the antibodies penetrate the tissue and bind to the basement membrane. AL-5 reacts with clusters of cells 
close to the basement membrane (H). Scale bars, 100 pm. 
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FIG. 4. Lung organ cultures were established on Day 0 and incubated 
for 2 days in the presence of 100 pg/ml of normal rat IgG, normal rat 
IgM, or mononuclear antibodies AL-l, Al-2, Al-3, AL-4, and AL-5. The 
percentage of branching inhibition was then calculated according to 
the formula shown under Materials and Methods. Percentages of inhi- 
bition 2 standard deviations are represented in this figure. Branching 
inhibition was observed in the explants exposed to AL-1 and AL-5. 
Both were statistically significant (P > 0.005, AL-l; P > 0.0001, AL-5). 
domain of laminin that recognized antibody AL-5 has 
heparin binding activity (Skubitz et al., 1988) and se- 
quences of amino acids from this domain have been 
found to promote both cell adhesion and heparin bind- 
ing (Charonis et ab, 1988; Kouzi-Koliakos et al., 1989). 
Not all of the domains with cell and/or heparin bind- 
ing activity appear to be involved in branching morpho- 
genesis. The YIGSR-containing sequence, located near 
the intersection of the cross on the Bl chain of laminin 
(i.e., the domain recognized by antibody AL-3), pro- 
motes the attachment of numerous cell lines (Graf et al., 
1987; Iwamoto et al, 1988), whereas the globular end of 
the long arm, another established cell binding domain 
(Aumailley et ab, 1987; Goodman et al., 198’7), is recog- 
nized by AL-4. However, antibodies against these do- 
mains did not affect morphogenesis. It can be suggested 
that although laminin contains multiple cell adhesion- 
promoting domains, not all of them play a role in 
branching morphogenesis at this stage of lung develop- 
ment. 
In addition to facilitating adhesion, laminin is also 
known to have direct mitogenic activity for some cells. 
This effect has been localized to the inner segments of 
the short arms, close to the cross intersection in regions 
that are rich in epidermal growth factor-like repeats in 
their amino acid sequence (Panayotou et al., 1989). The 
lack of inhibitory effect on branching development with 
antibody AL-3 (which binds to this region) seems to indi- 
cate that the effect of laminin on lung morphogenesis is 
not related to epidermal growth factor-like activity. 
Likewise, the long arm of the laminin molecule has been 
reported to play a role in the induction of polarization of 
tubular epithelium during embryonic kidney develop- 
ment (Klein et al, 1988). Antibody AL-Z, directed 
against this region, did not alter epithelial polarization 
of the newly formed airways. The lack of effect with this 
antibody might indicate that cell polarization in the 
lung involves different mechanisms than those acting in 
the kidney. The process of conversion of mesenchyme 
into an epithelium, as occurs in the kidney, is quite dif- 
ferent from the same process in the lung, in which a 
fully polarized epithelium proliferates and branches. 
In conclusion, two regions of the laminin molecule 
(i.e., the cross section and the globular regions of the 
lateral short arms) play a role in lung branching mor- 
phogenesis. Both domains regulate epithelium and mes- 
enchyme growth and branching morphogenesis. Both 
domains have in common their expression in the base- 
FIG. 5. Histological examination of mouse lung tissue in organ culture. Longitudinal sections through explants maintained in culture for 3 
days in the presence of 100 pg/ml of normal rat IgG (A) or in 100 rg/ml of AL-5 (B). The tissues demonstrate good viability with full 
architectural presentation. Scale bar, 50 pm. 
ment membrane as well as diffuse expression in the ex- 
tracellular matrix. 
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